학술논문

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy
Document Type
Article
Source
In: PLoS ONE. (PLoS ONE, January 2024, 19(1 January))
Subject
Language
English
ISSN
19326203